KHANDELWAL, PRAVEEN
KHANDELWAL, PRAVEEN
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways
2019 Magistroni, V; Mauri, M; D'Aliberti, D; Mezzatesta, C; Crespiatico, I; Nava, M; Fontana, D; Sharma, N; Parker, W; Schreiber, A; Yeung, D; Pirola, A; Redaelli, S; Massimino, L; Wang, P; Khandelwal, P; Citterio, S; Viltadi, M; Bombelli, S; Rigolio, R; Perego, R; Boultwood, J; Morotti, A; Saglio, G; Dong-Wook, K; Branford, S; Gambacorti Passerini, C; Piazza, R
Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients
2017 Mologni, L; Piazza, R; Khandelwal, P; Pirola, A; Gambacorti-Passerini, C
Elucidating the oncogenic role of genetic events in BCR-ABL1 positive chronic myeloid leukemia
2016 Khandelwal, P
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis
2016 Piazza, R; Mologni, L; Ramazzotti, D; Spinelli, R; Pirola, A; De Sano, L; Ferrari, P; Magistroni, V; Sharma, N; Khandelwal, P; Gambacorti-Passerini, C
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
2015 Sharma, N; Magistroni, V; Piazza, R; Citterio, S; Mezzatesta, C; Khandelwal, P; Pirola, A; GAMBACORTI PASSERINI, C